Fluoride

Fluoride

SCHEMBL27447648

CCCCS(=O)(=O)O.F.F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.50
▸ EPHX2 P34913 1/20 0.44
▸ LMNA P02545 3/20 0.44
▸ TP53 P04637 2/20 0.44
▸ S1PR2 O95136 2/20 0.44
▸ S1PR1 P21453 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ S1PR4 O95977 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ XBP1 P17861 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ AGTR1 P30556 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL11759407 1.00 — —
Fluoride SCHEMBL27460461 0.97 APP (0.48) APPEPHX2LMNATP53S1PR2
Fluoride SCHEMBL27813553 0.97 APP (0.48) APPEPHX2LMNATP53S1PR2
Fluoride SCHEMBL28021334 0.97 APP (0.48) APPEPHX2LMNATP53S1PR2
Fluoride SCHEMBL27590430 0.97 APP (0.48) APPEPHX2LMNATP53S1PR2
Fluoride SCHEMBL27883105 0.97 APP (0.48) APPEPHX2LMNATP53S1PR2
Hydrochloric Acid SCHEMBL28099472 0.97 APP (0.48) APPEPHX2LMNATP53S1PR2
Bromide SCHEMBL28848302 0.97 APP (0.48) APPEPHX2LMNATP53S1PR2
Fluoride SCHEMBL28255739 0.97 APP (0.48) APPEPHX2LMNATP53S1PR2
SCHEMBL10012319 0.97 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103038212-B Process for preparation of 3-substituted-4-fluoropyrrolidine derivatives KYORIN SEIYAKU KK 2015-04-22 — — CN claimed
CN-102105442-B Aqueous methods for making fluorinated sulfonate esters 3M INNOVATIVE PROPERTIES CO 2014-08-06 — — CN claimed
CN-103038212-A Process for preparation of 3-substituted-4-fluoropyrrolidine derivatives KYORIN SEIYAKU KK 2013-04-10 — — CN claimed
CN-101528721-B Process for the preparation of (s)-4-fluoromethyl-dihydro-furan-2-one HOFFMANN LA ROCHE 2013-01-02 — — CN claimed
CN-101323597-B Preparation of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amido) pyrimidine-5-formaldehyde ANHUI QINGYUN PHARMACEUTICAL AND CHEMICAL CO LTD 2012-09-05 — — CN claimed
CN-101578254-A Process for producing optically active alpha-fluorocarboxylic acid ester CENTRAL GLASS CO LTD (JP) 2009-11-11 — — CN claimed
CN-101528721-A Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one HOFFMANN LA ROCHE (CH) 2009-09-09 — — CN claimed
CN-101323597-A Preparation of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amido) pyrimidine-5-formaldehyde ANHUI QINGYUN PHARMACEUTICAL A (CN) 2008-12-17 — — CN claimed
CN-105452233-A Piperidine and azepane derivatives as prokineticin receptor modulators TAKEDA PHARMACEUTICALS CO 2016-03-30 — — CN disclosed
CN-103827133-B Estra-1, 3,5(10), 16-tetraene-3-carboxamide derivatives, method for the production thereof, pharmaceutical preparations containing the same, and use thereof for producing medicaments BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-25 — — CN disclosed
CN-105008382-A Estra-1, 3,5(10), 16-tetraene-3-carboxamides for the inhibition of 17 beta-hydroxysteroid dehydrogenase (AKR 1C 3) Bayer Pharma AG 2015-10-28 — — CN disclosed
CN-103080080-B 6,7-dihydro-5H-benzo [7] takes turns ene derivative, its preparation method, the pharmaceutical preparation comprising it and its purposes for the preparation of medicine BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-08-26 — — CN disclosed
CN-104781259-A BET protein inhibiting 5-aryltriazoloazepines Bayer Pharma AG 2015-07-15 — — CN disclosed
CN-103596941-B Anti-viral compounds ABBVIE INC 2015-07-08 — — CN disclosed
CN-1527821-A Process for preparing aminopyrimidine compounds — 2004-09-08 — — CN disclosed
CN-1419558-A Process for preparing camptothecin YAKULT HONSHA KK (JP) 2003-05-21 — — CN disclosed
CN-1106371-C Liquid crystal compounds having perfluoroether terminal moieties MINNESOTA MINING & MFG (US) 2003-04-23 — — CN disclosed
CN-1292005-A Substantially fluorinated ionomers DU PONT (US) 2001-04-18 — — CN disclosed
CN-1166823-A Liquid crystal compounds having perfluoroether terminal portions MINNESOTA MINING & MFG (US) 1997-12-03 — — CN disclosed
CN-1066271-A 14 β-H-14-and 15-ethylene linkage-11 beta-aryl-4-estrene SCHERING AG (DE) 1992-11-18 — — CN disclosed
Send feedback